Windtree Therapeutics, Inc.
WINT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 50% |
| R&D Expenses | $2 | $2 | $2 | $2 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $16 | $0 | $0 | $1 |
| Operating Expenses | $20 | $4 | $4 | $6 |
| Operating Income | $0 | -$4 | -$4 | -$6 |
| % Margin | – | – | – | -6,156.7% |
| Other Income/Exp. Net | $0 | -$7 | $0 | $8 |
| Pre-Tax Income | -$32 | -$11 | -$4 | $3 |
| Tax Expense | $3 | $0 | $0 | -$0 |
| Net Income | -$29 | -$11 | -$4 | $3 |
| % Margin | – | – | – | 3,074.4% |
| EPS | -1.08 | -3.06 | -4.63 | 0.27 |
| % Growth | 64.7% | 33.9% | -1,814.8% | – |
| EPS Diluted | -1.08 | -3.06 | -4.63 | 0.27 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | -$0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$11 | -$4 | $3 |
| % Margin | – | – | – | 3,076.7% |